Table 1 Dermatological conditions in the Case Mix Programme Database
Condition | ICU admissions, n (%*) | ICU deaths, n (%) | ICU transfers, n (%) | Ultimate hospital deaths, n (%) |
|---|---|---|---|---|
Infective conditions: | ||||
Necrotising fasciitis | 1,133 (0.24) | 336 (29.7) | 56 (4.9) | 438 (41.6) |
Cutaneous cellulitis | 658 (0.14) | 193 (29.3) | 14 (2.1) | 274 (42.6) |
Orbital cellulitis | 48 (0.01) | 8 (16.7) | 1 (2.1) | 12 (26.7) |
Wound infection† | 28 (0.01) | 2 (7.1) | 0 (0.0) | 10 (35.7) |
Infected ulcer† | 27 (0.01) | 10 (37.0) | 0 (0.0) | 17 (65.4) |
Abscess† | 23 (< 0.01) | 2 (8.7) | 1 (4.3) | 4 (18.2) |
Gangrene† | 6 (< 0.01) | 1 (16.7) | 0 (0.0) | 1 (16.7) |
Infected eczema† | 3 (< 0.01) | 1 (33.3) | 0 (0.0) | 1 (33.3) |
Dermatological malignancies: | ||||
Cutaneous melanoma | 80 (0.02) | 6 (7.5) | 0 (0.0) | 13 (16.9) |
Basal cell carcinoma | 96 (0.02) | 6 (6.3) | 0 (0.0) | 11 (12.0) |
Squamous cell carcinoma† | 15 (< 0.01) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Acute skin failure: | ||||
Toxic epidermal necrolysis | 86 (0.02) | 32 (37.2) | 5 (5.8) | 43 (50.6) |
Stevens–Johnson syndrome | 46 (0.01) | 14 (30.4) | 5 (10.9) | 19 (46.3) |
Erythema multiforme | 19 (< 0.01) | 3 (15.8) | 2 (10.5) | 6 (31.6) |
Psoriasis and pustular psoriasis | 19 (< 0.01) | 8 (42.1) | 0 (0.0) | 8 (42.1) |
Exfoliative dermatitis | 16 (< 0.01) | 7 (43.8) | 0 (0.0) | 7 (43.8) |
Pemphigus vulgaris | 9 (< 0.01) | 4 (44.4) | 0 (0.0) | 4 (44.4) |
Cutaneous T cell lymphoma† | 2 (< 0.01) | 1 (50.0) | 0 (0.0) | 2 (100.0) |
Staphylococcal scalded skin syndrome† | 1 (< 0.01) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Epidermolysis bullosa† | 1 (< 0.01) | 1 (100.0) | 0 (0.0) | 1 (100.0) |
Other: | ||||
Scleroderma | 36 (0.01) | 15 (41.7) | 1 (2.8) | 19 (54.3) |
Rash due to systemic infection† | 18 (< 0.01) | 3 (16.7) | 1 (5.6) | 5 (38.5) |
Pressure sores† | 10 (< 0.01) | 2 (20.0) | 0 (0.0) | 3 (33.3) |
Allergic reaction† | 7 (< 0.01) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Allergy testing† | 5 (< 0.01) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Complication following skin surgery for non malignant condition† | 4 (< 0.01) | 1 (25.0) | 0 (0.0) | 1 (25.0) |
Dermatomyositis† | 2 (< 0.01) | 1 (50.0) | 0 (0.0) | 2 (100.0) |
Pyoderma gangrenosum† | 2 (< 0.01) | 2 (100.0) | 0 (0.0) | 2 (100.0) |
Weber-Christian disease† | 1 (< 0.01) | 0 (0.0) | 0 (0.0) | 1 (100.0) |
Behçet's syndrome† | 1 (< 0.01) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Wegener's granulomatosis† | 1 (< 0.01) | 1 (100.0) | 0 (0.0) | 1 (100.0) |
Hypereosinophilia† | 1 (< 0.01) | 1 (100.0) | 0 (0.0) | 1 (100.0) |
Radiation necrosis† | 1 (< 0.01) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Axillary hyperhidrosis (thoracic sympathectomy)† | 1 (< 0.01) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Total | 2,406 (0.51) | 661 (27.5) | 86 (3.6) | 906 (39.6) |